Phoenix Pharmaceuticals, Inc.
Leader in Peptide Research. ELISA kits, Antibodies, Custom Peptide Synthesis.
Leader in Peptide Research. ELISA kits, Antibodies, Custom Peptide Synthesis.
Phoenix Pharmaceuticals, Inc. is a renowned leader in peptide research, offering an impressive range of over 7,000 peptide-related products to researchers worldwide. The company specializes in providing ELISA kits, peptides, custom peptide synthesis, and antibodies, with a focus on critical fields such as Obesity, Cardiovascular, Alzheimer's, and Diabetes. Established in 1994 and based in the United States, Phoenix Pharmaceuticals operates within the Biotechnology, Health Care, and Manufacturing industries. Notably, the company has not disclosed its most recent investment details or the involved investors. Phoenix Pharmaceuticals' dedication to advancing peptide research positions it as an intriguing potential investment opportunity within the biotechnology and healthcare sectors. With its extensive product range and focus on impactful medical areas, the company showcases potential for future growth and innovation.
There is no investment information
No recent news or press coverage available for Phoenix Pharmaceuticals, Inc..
We care about your data, and we'd love to use cookies make your experience better.
